Cardiovascular disease is the leading cause of mortality in the Western world. The number of patients diagnosed with coronary heart disease, heart failure, cerebrovascular disease, peripheral arterial disease, deep vein thrombosis, pulmonary embolism, hypertension and hyperlipidemia is increasing. Causes include better survival from myocardial infarction, and comorbid conditions such as obesity, and smoking. The high morbidity and mortality of Cardiac Disease has lead to many new investigational therapies and devices.
ICON Medical Imaging’s role as a medical imaging and endpoint core laboratory is to help sponsors assess the effect of therapies by independent and rigorous assessment of clinical and imaging endpoints. ICON Medical Imaging accomplishes this through the use of:
Advanced Science
ICON Medical Imaging has significant experience in all cardiovascular imaging modalities including Echo, Angiography, SPECT, CT, MRI, Ultrasound and ECGs. ICON Medical Imaging provides personal, one-on-one interaction and consulting on the critical uses of imaging in your trials, including the medical, scientific and regulatory aspects. Our people are imaging experts, with deep clinical and scientific roots.
Experienced People
ICON Medical Imaging has the most experienced cardiovascular team in the Commercial Core Laboratory Sector. ICON Medical Imaging’s cardiovascular project team is led by Dr. Jonathan Goldman, MD, FACC. Dr. Goldman is the Chief Medical Officer and Assistant Clinical Professor of Medicine, UCSF, and also an Honorary Consultant Cardiologist at the John Radcliffe Hospital Oxford. Dr. Goldman is a practicing Cardiologist with extensive experience with Clinical Trial Design and Execution and Cardiac Imaging including Echocardiography, Angiography and SPECT. He also has extensive regulatory experience with the FDA Medical Imaging Division. Dr. Goldman works closely with sponsors in study design, regulatory and biostatistical issues and study execution.
Dr. Goldman’s team of experienced imaging personnel includes:
- Cardiac Scientific Advisory Board comprised of world experts in several cardiac disciplines and adjudication
- In-house Nuclear Medicine Physician and Radiologist
- Network of Cardiac Image Blinded Readers for both remote and monitored reads in all modalities
- Cardiology Research Fellows at UCSF and Oxford
- Imaging Specialists with experience in CT, MR, Vascular Ultrasound, Angiography, Nuclear Medicine, Echo and SPECT
- Nuclear/Echo Cardiologists
- Biomedical Engineers
- Biostatistician
- Data Management
- Medical Writers
Superior Technology
ICON Medical Imaging provides image data, ECG and project management in a single system called MIRATM. MIRATM provides the ability to analyze all data in a fully electronic, 21 CFR Part 11 compliant environment with integrated eCRF capture. The combination of regulatory experience and technological innovation also facilitates fast blinded read setup. MIRATM was designed to facilitate sponsor timeline management by allowing up-to-the-minute access of dataflow and image reads.
To learn more about how ICON Medical Imaging can help you with your next Cardiovascular trial, contact us today.